Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
CardieX ( (AU:CDX) ) just unveiled an update.
CardieX Limited has announced a change in the director’s interest, specifically involving Charlie Taylor, who has acquired additional securities through the CW Taylor Family Trust. This acquisition was part of a director placement approved at the company’s May 2025 Extraordinary General Meeting, reflecting strategic financial maneuvers that could influence the company’s market position and shareholder value.
More about CardieX
CardieX Limited operates in the medical technology industry, focusing on the development and commercialization of cardiovascular health solutions. The company is known for its innovative products aimed at improving heart health and monitoring, catering to both consumer and clinical markets.
Average Trading Volume: 244,250
Technical Sentiment Signal: Sell
Current Market Cap: A$21.07M
For a thorough assessment of CDX stock, go to TipRanks’ Stock Analysis page.